Navigating phenylketonuria management to improve it in Latin America: a systematic literature review and

Alex S Aguirre1, Edison Haro1, Alberto Campodónico1

  • 1School of Medicine, Universidad San Francisco de Quito, Quito, Ecuador.

PubMed

Insights

Phenylketonuria (PKU) management requires lifelong low-phenylalanine diets and multidisciplinary care. Latin America faces challenges in PKU care, including limited resources and healthcare access, necessitating collaborative efforts for improved patient outcomes.

Area of Science:

  • Metabolic Disorders
  • Neurodevelopmental Disorders
  • Genetics

Background:

  • Phenylketonuria (PKU) is an inherited metabolic disorder affecting phenylalanine metabolism and neurodevelopment.
  • Effective PKU management relies on lifelong adherence to low-phenylalanine diets and comprehensive multidisciplinary care.
  • Latin America presents unique challenges in PKU care, including fragmented newborn screening and resource limitations.

Purpose of the Study:

  • To systematically review current PKU management guidelines and practices.
  • To identify key principles and challenges in PKU care, particularly within the Latin American context.
  • To inform strategies for enhancing PKU diagnosis and management in the region.

Main Methods:

  • A systematic literature review was conducted from 2010 to 2023, adhering to PRISMA guidelines.
  • Inclusion criteria focused on PKU management guidelines and PKU care in Latin America, published in English or Spanish.
  • A rigorous screening process identified 6 relevant articles from over 127,000 initial results.

Main Results:

  • Key management principles include multidisciplinary teams, lifelong dietary adherence, personalized care plans, and regular monitoring.
  • Regional variations, challenges in breastfeeding, and specific needs of pregnant women with PKU were highlighted.
  • Latin American PKU care is impacted by healthcare gaps, resource scarcity, and reliance on international protocols.

Conclusions:

  • Multidisciplinary care involving physicians, dietitians, psychologists, and genetic counselors is crucial for optimal PKU management.
  • Addressing healthcare gaps, resource limitations, and promoting regional collaboration are essential for improving PKU care in Latin America.
  • Enhanced awareness, specialized training, and international partnerships can significantly improve diagnosis and long-term outcomes for individuals with PKU.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
153
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
977
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
340